AbbVie — Drug Prices & Medicare Spending

AbbVie manufactures 15 drugs tracked by Medicare Part D with total spending of $16.8B.

Drugs Tracked

$16.8B

Medicare Spending

$311.67

Avg Cost/Claim

80%

Have Generics

AbbVie Drugs — Ranked by Medicare Spending

#	Drug	Generic Name	Cost/Claim	Medicare Spending	YoY Change	Generic?
1	Humira	Adalimumab	$3,414.00	$6.5B	-22.1%	Yes
2	Skyrizi	Risankizumab	$4,475.00	$2.3B	+42.8%	No
3	Rinvoq	Upadacitinib	$3,498.00	$2.3B	+56.3%	No
4	Vraylar	Cariprazine	$383.00	$1.7B	+26.3%	No
5	Mavyret	Glecaprevir/Pibrentasvir	$26,250.00	$945.0M	-21.4%	Yes
6	Linzess	Linaclotide	$180.00	$876.0M	+6.4%	Yes
7	Ubrelvy	Ubrogepant	$305.00	$567.0M	+32.4%	Yes
8	Qulipta	Atogepant	$528.00	$456.0M	+86.4%	Yes
9	Synthroid	Levothyroxine	$14.00	$345.0M	-8.4%	Yes
10	Orilissa	Elagolix	$552.00	$234.0M	-4.8%	Yes
11	Depakote	Divalproex Sodium (brand)	$72.00	$178.0M	-22.4%	Yes
12	Divalproex	Divalproex Sodium	$30.00	$145.0M	-14.2%	Yes
13	Fenofibrate	Fenofibrate	$25.00	$123.0M	-14.2%	Yes
14	Niaspan	Niacin ER	$143.00	$89.0M	-32.4%	Yes
15	Trilipix	Fenofibric Acid	$103.00	$89.0M	-24.6%	Yes

AbbVie manufactures 15 drugs tracked by Medicare Part D, with total annual spending of $16.8B.

Mavyret (Glecaprevir/Pibrentasvir) is the most expensive at $26,250.00 per claim.

12 of 15 AbbVie drugs (80%) have generic alternatives available. Generic drugs can save patients 30-80% compared to brand-name versions.